Login

Username:

Password:

Forgot your password? Not a member yet? Click here to register

The NHMRC has allocated AUD $4m to support a small number of collaboratively funded projects received in response to CIRM Awards (RFA11-02: CIRM Early Translational Awards III). An NHMRC research grant of up to 3 years duration will be offered to support project work to be conducted by Partner Investigators located in Australia. Pre-applications opened 30 June 2011. 

 

Pre-applications must be submitted to CIRM online through the CIRM Grants Management Portal by 5:00 pm (Pacific Daylight Time) on 10 August 2011.Further information and a Request for Application form is available on the CIRM website. Download information about RFA11-02 here.

  

The European Commission's Seventh Framework Programme (FP7) includes a call on regenerative medicine that opens in July for projects starting in late 2012/early 2013. Australian organisations can participate and are eligible to seek funding from the NHMRC's NHMRC - European Union Collaborative Research Grants (subject to the scheme guidelines). Industrial partners and SMEs will have to be involved in the targeted call. Please visit NHMRC - EU Collaborative Research Grants for further information.

The targeted topic: Innovative strategies for translation of stem cell based therapies in regenerative medicine. Projects should aim to develop innovative strategies to stem cell-based therapies based on various approaches including allogeneic and/or autologous sources, with an emphasis on understanding the mechanisms of action and nature of the host response. Proposals should include thorough characterisation, quality control of the product(s), efficacy and safety in relevant pre-clinical models and, if possible, early assessment in humans or relevant bridging studies. The selected project should capitalise on the strong expertise and synergistic opportunities available in Australia and Europe in the fields of stem cell biology, cell-host interactions, and bioengineering, bio-processing and clinical trial management. Therapeutic products and clinical protocols should be developed through collaboration with industry partners and in consultation with appropriate regulatory bodies and health economic advisors. Part of the research project will be carried out by Australian partners in Australia and will be financed locally. Industrial participation is required. 

The ASSCR in coordination with the Forum for European-Australian Science and Technology co-operation called FEAST will provide a link between Australian stem cell researchers or companies with European partners. The ASSCR will forward information to Australian researchers or companies. If you are interested in finding a European partner, please email info(at)asscr.org.